# Adductor Canal Block

> **NCT04513145** · PHASE2,PHASE3 · TERMINATED · sponsor: **OrthoCarolina Research Institute, Inc.** · enrollment: 93 (actual)

## Conditions studied

- Osteoarthritis
- Total Knee Replacement

## Interventions

- **DRUG:** Ropivacaine injection
- **DRUG:** Saline Injection
- **PROCEDURE:** Total Knee Arthroplasty

## Key facts

- **NCT ID:** NCT04513145
- **Lead sponsor:** OrthoCarolina Research Institute, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-10-09
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-05-23
- **Target enrollment:** 93 (ACTUAL)
- **Why stopped:** Principal Investigator left the lead site. New Principal Investigator was not selected. Project was discontinued.
- **Last updated:** 2026-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04513145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04513145, "Adductor Canal Block". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04513145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*